What is it about?
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of hematopoietic stem cells. Although there have been advancements in treatment, there is still a need to develop a biotherapeutic agent. A new variant of the human alpha-lactalbumin-oleic acid (HALOA) complex has been synthesized, which showed similarities with SNARE.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
Novel Biotherapeutic agent.
Perspectives
HALOA complex shows that SNARE-like behavior can be used as a promising anti-tumor agent with lower toxicity and maximum bioavailability.
Dr. Vivek Singh
King George's Medical University
Read the Original
This page is a summary of: A new variant of the human α-lactalbumin-oleic acid complex as an anticancer agent for chronic myeloid leukemia, Journal of Medicine and Life, January 2021, Fundatia Jurnalului Journal of Medicine and Life,
DOI: 10.25122/jml-2021-0065.
You can read the full text:
Contributors
The following have contributed to this page
